Headline Roundup • December 12th, 2020
FDA Authorizes Pfizer COVID-19 Vaccine for Emergency Use
Summary from the AllSides News Team
Featured Coverage of this Story
Reuters
The United States said it authorized the use of Pfizer Inc’s COVID-19 vaccine on Friday, with the first inoculations expected within days, marking a turning point in a country where the pandemic has killed more than 295,000 people. The U.S. Food and Drug Administration granted an emergency use authorization for the vaccine, developed with German partner BioNTech, which was shown to be 95% effective in preventing the disease in a late-stage trial. It said the vaccine can be given to people aged 16 and older.
Healthcare workers and elderly people...
The Food and Drug Administration on Friday authorized Pfizer's coronavirus vaccine for emergency use, kicking off a massive effort to initially deliver nearly 3 million doses of the vaccine to more than 600 sites nationwide. The approval comes just a day after the FDA's advisory panel voted 17-4 in favor of approving the vaccine.
Frontline medical workers and residents of long-term care facilities will be the first to get the vaccine, and could receive it as early as Monday. The vaccine is authorized for people age 16 and older, the...
The FDA has approved Pfizer’s COVID-19 vaccine through an emergency use authorization, clearing the way for Americans to receive inoculations against COVID-19 for the first time since the pandemic was declared in March, according to multiple reports.
Under the emergency authorization, high-priority Americans will begin receiving the first of two inoculations against COVID-19, possibly within hours, according to previous remarks made by Pfizer CEO Albert Bourla. The CDC expects Pfizer to have 25 million doses available this month.
AllSides Picks
Blog
Mass Kidnappings, Covid Contingencies, ICE Controversies: Stories You May Have Missed
Malayna J. Bizier
June 18th, 2026
Red Blue Translator
Anti-vaxxer
